Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVpc Specialty Regulatory News (VSL)

Share Price Information for Vpc Specialty (VSL)

Share Price is delayed by 15 minutes
Get Live Data
11.00    0.00 (0.00%)
Bid:
10.75
Ask:
11.75
Spread: 1.00 (9.302%)
Market Cap: £30.61m
VSL Live PriceLast checked at - London Stock Exchange

Intraday Vpc Specialty Share Chart

Holding(s) in Company

2 Feb 2017 14:32

RNS Number : 9055V
VPC Specialty Lending Invest. PLC
02 February 2017
 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

VPC Specialty Lending Investments PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

City Financial Investment Company Limited, acting as Investment Manager of the City Financial Wealth Fund, City Financial Diversified Fixed Interest Fund, City Financial Multi Asset Diversified Fund, City Financial Multi Asset Balanced Fund and the City Financial Multi Asset Growth Fund

4. Full name of shareholder(s)  (if different from 3.):iv

BNY Mellon Trust and Depositary as Trustee to the City Financial Multi Asset Diversified Fund, City Financial Multi Asset Balanced Fund, City Financial Multi Asset Growth Fund and the City Financial Diversified Fixed Interest Fund and NorTrust Nominees Ltd acting as Trustee to the City Financial Wealth Fund

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

31 Jan 2017

6. Date on which issuer notified:

2 Feb 2017

7. Threshold(s) that is/are crossed orreached: vi, vii

5%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

 

GB00BVG6X439

19,098,788

19,098,788

18,898,788

18,898,788

4.97%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

18,898,788

4.97%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

N/A

 

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will ceaseto hold:

N/A

12. Date on which proxy holder will cease to holdvoting rights:

N/A

13. Additional information:

14. Contact name:

Chris Sturdee

15. Contact telephone number:

020 7451 9600

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLLLFVSFIIFIID
Date   Source Headline
13th May 20267:00 amRNSNet Asset Value(s)
28th Apr 20267:00 amRNSAnnual Financial Report
27th Feb 20264:50 pmRNSDividend Declaration
18th Feb 20267:00 amRNSNet Asset Value(s)
27th Jan 20262:43 pmRNSHolding(s) in Company
22nd Jan 20263:03 pmRNSHolding(s) in Company
12th Jan 20264:01 pmRNSNet Asset Value(s)
4th Dec 20255:51 pmRNSDividend Declaration
4th Dec 20253:13 pmRNSHolding(s) in Company
2nd Dec 20252:57 pmRNSHolding(s) in Company
21st Nov 20257:00 amRNSNet Asset Value(s)
20th Nov 20253:02 pmRNSHolding(s) in Company
27th Oct 20255:35 pmRNSHolding(s) in Company
23rd Oct 20255:20 pmRNSHolding(s) in Company
15th Oct 20253:21 pmRNSHolding(s) in Company
13th Oct 20254:06 pmRNSHolding(s) in Company
2nd Oct 20255:34 pmRNSHolding(s) in Company
26th Sep 20257:00 amRNSHalf-year Report
25th Sep 20253:45 pmRNSHolding(s) in Company
24th Sep 20253:25 pmRNSHolding(s) in Company
22nd Sep 20255:35 pmRNSResult of GM
19th Sep 20259:34 amRNSHolding(s) in Company
4th Sep 20252:54 pmRNSNotice of GM
2nd Sep 20259:13 amRNSHolding(s) in Company
28th Aug 20253:51 pmRNSHolding(s) in Company
22nd Aug 20257:00 amRNSNet Asset Value(s)
19th Aug 20254:24 pmRNSHolding(s) in Company
18th Aug 20252:40 pmRNSHolding(s) in Company
14th Aug 20253:08 pmRNSHolding(s) in Company
13th Aug 20253:55 pmRNSHolding(s) in Company
12th Aug 20253:25 pmRNSHolding(s) in Company
11th Aug 20255:39 pmRNSHolding(s) in Company
6th Aug 20253:25 pmRNSBoard Update
26th Jun 20253:59 pmRNSHolding(s) in Company
24th Jun 20251:03 pmRNSHolding(s) in Company
20th Jun 20255:22 pmRNSHolding(s) in Company
12th Jun 202510:51 amRNSResult of AGM
12th Jun 20257:00 amRNSDividend Declaration
2nd Jun 20253:00 pmRNSNet Asset Value(s)
20th May 20257:00 amRNSSecond Return of Capital Exchange Ratio
12th May 20257:00 amRNSSecond Return of Capital through B Share Scheme
8th May 20254:30 pmRNSNotice of AGM
25th Apr 20257:00 amRNSAnnual Financial Report
27th Feb 20257:05 amRNSUpdate
27th Feb 20257:00 amRNSDividend Declaration
19th Feb 20259:59 amRNSNet Asset Value(s)
13th Feb 20254:58 pmRNSHolding(s) in Company
23rd Dec 202411:40 amRNSUpdate
18th Nov 20244:31 pmRNSHolding(s) in Company
13th Nov 20247:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.